Preclinical Studies in Normal Canine Prostate of a Novel Palladium-Bacteriopheophorbide (WST09) Photosensitizer for Photodynamic Therapy of Prostate Cancer¶

Keywords

Photodynamic therapy, Photosensitizer, Prostate, Rectum, Medicine

References

• Randomized series of treatment with surgery versus radiation for prostate adenocarcinoma.David F. Paulson — 1988
• Photodynamic therapy of orthotopic prostate cancer with benzoporphyrin derivative: local control and distant metastasis.Tetsuo Momma, Michael R. Hamblin, Horace Wu — 1998
• Theory and Practice of HistotechnologyDezna C. Sheehan, Barbara B. Hrapchak — 1980
• Laser Dosimetry Studies in the ProstateQun Chen, Fred W. Hetzel — 1998
• Tumor-specific and Photodependent Cytotoxicity of Hypericin in the Human LNCaP Prostate Tumor ModelXiaowei Xie, James B. Hudson, Emma S. Tomlinson Guns — 2001
• Photodynamic activities of silicon phthalocyanines against achromic M6 melanoma cells and healthy human melanocytes and keratinocytes.Richard A. Decréau, Mireille Richard‐Plouet, Patrick Verrando — 1999
• Photodynamic therapy using 5-aminolaevulinic acid for experimental pancreatic cancer--prolonged animal survival.Jarosław Reguła, Bina Ravi, J Bedwell — 1994
• A Comparison of the Photodynamic Effects of Temoporfin (mTHPC) and MC540 on Leukemia Cells: Efficacy and ApoptosisJ. Y. Chen, Nai Ki Mak, Jin Wen — 1998
• Significance of Dosimetry in Photodynamic Therapy of Injured Arteries: Classification of Biological ResponsesFarzin Adili, Randolph G. Statius van Eps, Glenn M. LaMuraglia — 1999
• Results and Side Effects of High-Intensity Focused Ultrasound in Localized Prostate CancerC. Chaussy, S. Thüroff — 2001
• Cancer statistics, 1994C. C. Boring, T. S. Squires, T. Tong — 1994
• Interstitial and transurethral photodynamic therapy of the canine prostate using meso‐tetra‐(m‐hydroxyphenyl) chlorinShi‐Chung Chang, G. Buonaccorsi, Alexander J. MacRobert — 1996
• Transperineal photodynamic ablation of the canine prostate.Steven H. Selman, Rick W. Keck, James A. Hampton — 1996
• Hypericin photosensitization of tumor and metastatic cell lines of human prostate.Alberto Colasanti, Annamaria Kisslinger, Raffaele Liuzzi — 2000
• Photosensitizing efficacy of MTHPC‐PDT compared to Photofrin‐PDT in the RIF1 mouse tumour and normal skinI. P. J. van Geel, Hugo Oppelaar, Yvonne Oussoren — 2006
• Photodynamic therapy for colorectal cancer: A quantitative pilot studyHugh Barr, N Krasner, P B Boulos — 1990
• Effects of radiation on the normal prostate glandMichael Sheaff, Suhail Baithun — 1997
• Studies of tin ethyl etiopurpurin photodynamic therapy of the canine prostate.Steven H. Selman, Detlef Albrecht, Rick W. Keck — 2001
• Interstitial photodynamic therapy in the canine prostate.L. K. Lee, C. Whitehurst, Q. CHEN — 1997
• Fluorescence distribution and photodynamic effect of ALA-induced PP IX in the DMH rat colonic tumour model.J Bedwell, A. J. MacRobert, David R. Phillips — 1992

Cited by

• Determination of the in vivo pharmacokinetics of palladium-bacteriopheophorbide (WST09) in EMT6 tumour-bearing Balb/c mice using graphite furnace atomic absorption spectroscopyPhilip N. Hablutzel — 2004
• Enhancing Tumor Drug Delivery by Laser-Activated Vascular Barrier DisruptionBin Chen, Chong He — 2008
• Treatment of localized prostate cancer using WST-09 and WST-11 mediated vascular targeted photodynamic therapy-A review.A. Kawczyk-Krupka, Katarzyna Wawrzyniec, Szymon Musiol — 2015
• p53 family members — important messengers in cell death signaling in photodynamic therapy of cancer?Pilar Acedo, Joanna Zawacka‐Pankau — 2015
• One- and two-photon activated phototoxicity of conjugated porphyrin dimers with high two-photon absorption cross sections.Emma Dahlstedt, Hazel A. Collins, Milan Baláž — 2009
• Preclinical study of the novel vascular occluding agent, WST11, for photodynamic therapy of the canine prostate.Simone Chevalier, Maurice Anidjar, Eleonora Scarlata — 2011
• Bypass of tumor drug resistance by antivascular therapy.Dina Preise, Ohad Mazor, Natalia V. Koudinova — 2003
• Evaluation of the Photosensitizer Tookad® for Photodynamic Therapy on the Syrian Golden Hamster Cheek Pouch Model: Light Dose, Drug Dose and Drug–light Interval Effects¶François Borle, Alexandre Radu, Philippe Monnier — 2003
• In vivo optical characterization of human prostate tissue using near-infrared time-resolved spectroscopy.Tomas Svensson, Stefan Andersson‐Engels, Margrét Einarsdóttír — 2007
• Photodynamic therapy using meso tetra hydroxy phenyl chlorin (mTHPC) in early prostate cancerCaroline M. Moore, Timothy R. Nathan, W R Lees — 2006
• Real-time optoacoustic monitoring of vascular damage during photodynamic therapy treatment of tumor.Liangzhong Xiang, Da Xing, Huaimin Gu — 2007
• Tookad-mediated photodynamic effects on the prostate and its adjacent tissues: in vivo study in canine modelsZheng Huang, Qun Chen, David Luck — 2005
• Studies of a vascular‐acting photosensitizer, Pd‐bacteriopheophorbide (Tookad), in normal canine prostate and spontaneous canine prostate cancerZheng Huang, Qun Chen, David Luck — 2005
• New treatments for localized prostate cancer.Michael Marberger, Peter R. Carroll, Michael J. Zeléfsky — 2008
• Selectivity of the photosensitiser Tookad® for photodynamic therapy evaluated in the Syrian golden hamster cheek pouch tumour modelF Borle, Alexandre Radu, C Fontolliet — 2003
• Effects of heavy central metal on the ground and excited states of chlorophyllAgnieszka Drzewiecka‐Matuszek, Agnieszka Skalna, Andrzej Karocki — 2005
• Photodynamic therapy of established prostatic adenocarcinoma with TOOKAD: a biphasic apparent diffusion coefficient change as potential early MRI response marker.Vicki Plaks, Natalia V. Koudinova, Uri Nevo — 2004
• Selective synthesis of C32- and C20-monoiodinated chlorophyll derivativesToru Oba, Kota Miyata, Takuto Masuya — 2015
• Effects of Photodynamic Therapy on Peripheral Nerve: In Situ Compound-Action Potentials Study in a Canine ModelKenneth C. Dole, Qun Chen, Fred W. Hetzel — 2005
• Photodynamic therapy with Pd‐bacteriopheophorbide (TOOKAD): Successful in vivo treatment of human prostatic small cell carcinoma xenograftsNatalia V. Koudinova, Jehonathan H. Pinthus, Alexander Brandis — 2003

Related papers

• Fluorous photosensitizers enhance photodynamic therapy with perfluorocarbon nanoemulsionsEllen M. Sletten, Rachael A. Day, Daniel A. Estabrook — 2017
• Fluorous photosensitizers enhance photodynamic therapy with perfluorocarbon nanoemulsionsEllen M. Sletten, Rachael A. Day, Daniel A. Estabrook — 2017
• Fluorous photosensitizers enhance photodynamic therapy with perfluorocarbon nanoemulsions.Rachael A. Day, Daniel A. Estabrook, Jessica K. Logan — 2017
• Perfluorocarbon nanoparticles enhance reactive oxygen levels and tumour growth inhibition in photodynamic therapyYuhao Cheng, Hao Cheng, Chenxiao Jiang — 2015
• Research advances in action mechanisms of photodynamic therapy and photosensitizerShurui Shi, Yue Wang, Guoyun Wan — 2016
• Progress in the Synthesis of Photodynamic Therapy DrugsYang Chen — 2012
• Advances in photosensitizer-related design for photodynamic therapyZhaojie Zhou, Ling Zhang, Zhirong Zhang — 2021
• Role of Photosensitizer in Photodynamic TherapyGao Rui-xue — 2008
• Photodynamic therapy: novel third‐generation photosensitizers one step closer?Leanne B. Josefsen, R W Boyle — 2008
• Clinical Applications of Photodynamic Therapy and Photodynamic DiagnosisAkira Kaneda, Jiro MINEHISA — 2007